Home
About
Overview
Sharing Data
ORCID
Help
History (13)
CYP2D6 genotyping and tamoxifen: an unfinished story in the quest for personalized medicine.
The effects of brain death and ischemia on tolerance induction are organ-specific.
A response to "Personalised medicine and population health: breast and ovarian cancer".
Closing the Cancer Divide Through Ubuntu: Information and Communication Technology-Powered Models for Global Radiation Oncology.
Precision oncology: Directing genomics and pharmacogenomics toward reducing cancer inequities.
See All 13 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Precision oncology: Directing genomics and pharmacogenomics toward reducing cancer inequities.
Precision oncology: Directing genomics and pharmacogenomics toward reducing cancer inequities. Cancer Cell. 2021 06 14; 39(6):730-733.
View in:
PubMed
subject areas
Genetic Variation
Genome-Wide Association Study
Healthcare Disparities
Humans
Medical Oncology
National Institutes of Health (U.S.)
Neoplasms
Pharmacogenetics
Precision Medicine
United States
authors with profiles
Olufunmilayo Olopade
Loren Saulsberry